Supply and Support of Complete Antibody Quantification Testing Systems
Estimated value
—
Awarded value
£2.2m
Suppliers
1
Lots
1
Published
18 Feb 2026
Description
Anti-D and Anti-c Antibody Quantification NHS Blood & Transplant (NHSBT) Red Cell Immunohaematology (RCI) function is seeking to provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. Antibody (anti-D and anti-c) quantification is a vital component of RCI service, predominantly providing service to NHS hospitals. The test results play a crucial role in guiding the clinical management of alloimmunised ANC patients’ by predicting the risk of haemolytic disease of the foetus and newborn and triggering referral to an FMU specialist, In addition, quantification is used to assist in the laboratory differentiation of immune anti-D from passive anti-D Ig. The test is vital for identifying levels of alloimmune and prophylactic anti-D, as well as alloimmune anti-c in obstetric and other referrals.
Scope
- Reference
- C350958
- Commercial tool
- Standalone contract
- Contract dates
- 31 Mar 2026 to 31 Mar 2033
Three additional years available as monthly or cumulative extensions.
- CPV classifications
- 33100000
- Particular suitability
- Small and medium-sized enterprises (SME)
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Quality | Quality | quality | 40.00% |
| Price | Price | price | 60.00% |
Participation
Conditions suppliers must meet to bid.
The final requirements will be set out in the Tender Notice (UK04) and the Tender Documents when published (estimated 2nd September 2025).
Submission & procedure
- Procedure
- Competitive flexible procedure
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£2.2m
Award date
17 Feb 2026
Contract start
31 Mar 2026
Contract end
31 Mar 2033